Fig 1: Aortic BCL11B expression correlates with leukocyte markers. Plots of BCL11B mRNA against and CD8a (a), CD25 (b), and CD45 (c) transcript levels (n = 85) showing a strong positive correlation between BCL11B and these leukocyte markers. There is no correlation with the erythrocyte marker CD235a (d). For both SNPs, the genotypes are shown as filled symbols (CC black, CT black/white, and TT white)
Fig 2: Aortic expression of BCL11B. (a) Bar chart showing reduction in BCL11B mRNA expression in cultured human aortic vascular smooth muscle cells is insignificant compared to PBMC and HEK293T cells. (b) Representative western blot of aortic BCL11B shows negative staining across nuclear and cytoplasmic homogenates of (I) low PWV samples, (II) high PWV samples, and (III) samples with the highest BCL11B mRNA levels. Positive control is protein lysate of HEK293T-expressing full-length BCL11B and negative control is protein lysate of HEK293T expressing an empty vector control. (c) Representative immunohistochemical staining of (n = 45) aortic samples shows lack of BCL11B expression in the aorta. Tonsil was used as a positive control for the antibody (scale bar = 50 µM)
Fig 3: Association of 3’BCL11B gene desert SNPs with (a) calculated PWV and (b) BCL11B mRNA in human aortic tissues. Boxes are interquartile ranges, the lines within boxes are median values and whiskers are 5th and 95th percentiles. *P < 0.05 for comparison of the two homozygous genotypes
Supplier Page from Abcam for Anti-Ctip2 antibody [EPR12275(2)]